Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

Chronic myelomonocytic leukaemia is a rare disease and data on the treatment are often extrapolated from myelodysplastic syndrome studies. Although several scores exist for the prognosis of overall survival in chronic myelomonocytic leukaemia, so far there is no designated score for the prediction o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Weiss, Lukas, Faber, Viktoria, Neureiter, Daniel, Egle, Alexander, Geissler, Klaus, Voskova, Daniela, Zebisch, Armin, Burgstaller, Sonja, Pichler, Angelika, Stauder, Reinhard, Sperr, Wolfgang, Lang, Alois, Pfeilstöcker, Michael, Machherndl-Spandl, Sigrid, Stampfl, Margarete, Greil, Richard, Pleyer, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816094/
https://www.ncbi.nlm.nih.gov/pubmed/29383443
http://dx.doi.org/10.1007/s00508-018-1315-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816094/
https://www.ncbi.nlm.nih.gov/pubmed/29383443
http://dx.doi.org/10.1007/s00508-018-1315-2

Ejemplares similares